Curanex Pharmaceuticals Inc (CURX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
3/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseCURX / S&P -48.14% / 15.20% |
LoseCURX / S&P CURX unavailable / 15.00% |
WinCURX / S&P 1200.00% / 50.40% |
| 2026-Q12/3 |
WinCURX / S&P 54.38% / -4.33% |
LoseCURX / S&P CURX unavailable / 11.30% |
WinCURX / S&P 440.00% / 27.70% |
| 2025-Q40/3 |
LoseCURX / S&P -54.03% / 2.65% |
LoseCURX / S&P CURX unavailable / 9.00% |
LoseCURX / S&P CURX unavailable / 13.40% |
| 2025-Q30/3 |
LoseCURX / S&P CURX unavailable / 8.12% |
LoseCURX / S&P CURX unavailable / 4.61% |
LoseCURX / S&P CURX unavailable / 13.45% |
| 2025-Q20/3 |
LoseCURX / S&P CURX unavailable / 10.94% |
LoseCURX / S&P CURX unavailable / 4.83% |
LoseCURX / S&P CURX unavailable / 10.63% |
| 2025-Q10/3 |
LoseCURX / S&P CURX unavailable / -4.27% |
LoseCURX / S&P CURX unavailable / 4.98% |
LoseCURX / S&P CURX unavailable / 10.57% |
| 2024-Q40/3 |
LoseCURX / S&P CURX unavailable / 2.41% |
LoseCURX / S&P CURX unavailable / 5.25% |
LoseCURX / S&P CURX unavailable / 6.15% |
| 2024-Q30/3 |
LoseCURX / S&P CURX unavailable / 5.89% |
LoseCURX / S&P CURX unavailable / 5.89% |
LoseCURX / S&P CURX unavailable / 6.11% |
| 2024-Q20/3 |
LoseCURX / S&P CURX unavailable / 4.28% |
LoseCURX / S&P CURX unavailable / 5.38% |
LoseCURX / S&P CURX unavailable / 5.12% |
| 2024-Q10/3 |
LoseCURX / S&P CURX unavailable / 10.56% |
LoseCURX / S&P CURX unavailable / 5.71% |
LoseCURX / S&P CURX unavailable / 5.59% |
| 2023-Q40/3 |
LoseCURX / S&P CURX unavailable / 11.69% |
LoseCURX / S&P CURX unavailable / 6.81% |
LoseCURX / S&P CURX unavailable / 7.78% |
| 2023-Q30/3 |
LoseCURX / S&P CURX unavailable / -3.27% |
LoseCURX / S&P CURX unavailable / 7.52% |
LoseCURX / S&P CURX unavailable / -5.03% |
| 2023-Q20/3 |
LoseCURX / S&P CURX unavailable / 8.74% |
LoseCURX / S&P CURX unavailable / 9.50% |
LoseCURX / S&P CURX unavailable / -8.57% |
| 2023-Q10/3 |
LoseCURX / S&P CURX unavailable / 7.50% |
LoseCURX / S&P CURX unavailable / 10.77% |
LoseCURX / S&P CURX unavailable / -15.69% |
| 2022-Q40/3 |
LoseCURX / S&P CURX unavailable / 7.56% |
LoseCURX / S&P CURX unavailable / 11.88% |
LoseCURX / S&P CURX unavailable / -17.99% |
| 2022-Q30/3 |
LoseCURX / S&P CURX unavailable / -4.88% |
LoseCURX / S&P CURX unavailable / 13.47% |
LoseCURX / S&P CURX unavailable / -1.41% |
| 2022-Q20/3 |
LoseCURX / S&P CURX unavailable / -16.10% |
LoseCURX / S&P CURX unavailable / 13.71% |
LoseCURX / S&P CURX unavailable / 11.04% |
| 2022-Q10/3 |
LoseCURX / S&P CURX unavailable / -4.60% |
LoseCURX / S&P CURX unavailable / 15.97% |
LoseCURX / S&P CURX unavailable / 42.23% |
| 2021-Q40/3 |
LoseCURX / S&P CURX unavailable / 11.03% |
LoseCURX / S&P CURX unavailable / 15.00% |
LoseCURX / S&P CURX unavailable / 96.40% |
| 2021-Q30/3 |
LoseCURX / S&P CURX unavailable / 0.58% |
LoseCURX / S&P CURX unavailable / 10.77% |
LoseCURX / S&P CURX unavailable / 69.42% |
| 2021-Q20/3 |
LoseCURX / S&P CURX unavailable / 8.55% |
LoseCURX / S&P CURX unavailable / 6.58% |
LoseCURX / S&P CURX unavailable / 51.81% |
| 2021-Q10/3 |
LoseCURX / S&P CURX unavailable / 6.17% |
LoseCURX / S&P CURX unavailable / -1.06% |
LoseCURX / S&P CURX unavailable / 7.39% |
| 2020-Q40/3 |
LoseCURX / S&P CURX unavailable / 12.15% |
LoseCURX / S&P CURX unavailable / -3.72% |
LoseCURX / S&P CURX unavailable / -33.42% |
| 2020-Q30/3 |
LoseCURX / S&P CURX unavailable / 8.93% |
LoseCURX / S&P CURX unavailable / -2.04% |
LoseCURX / S&P CURX unavailable / -27.10% |
| 2020-Q20/3 |
LoseCURX / S&P CURX unavailable / 20.54% |
LoseCURX / S&P CURX unavailable / -0.46% |
LoseCURX / S&P CURX unavailable / -27.11% |
| 2020-Q10/3 |
LoseCURX / S&P CURX unavailable / -19.60% |
LoseCURX / S&P CURX unavailable / 3.47% |
LoseCURX / S&P CURX unavailable / -14.75% |
| 2019-Q40/3 |
LoseCURX / S&P CURX unavailable / 9.07% |
LoseCURX / S&P CURX unavailable / 5.36% |
LoseCURX / S&P CURX unavailable / 2.99% |
| 2019-Q30/3 |
LoseCURX / S&P CURX unavailable / 1.70% |
LoseCURX / S&P CURX unavailable / 5.02% |
LoseCURX / S&P CURX unavailable / 0.21% |
| 2019-Q20/3 |
LoseCURX / S&P CURX unavailable / 4.30% |
LoseCURX / S&P CURX unavailable / 6.64% |
LoseCURX / S&P CURX unavailable / 8.65% |
| 2019-Q10/3 |
LoseCURX / S&P CURX unavailable / 13.65% |
LoseCURX / S&P CURX unavailable / 8.12% |
LoseCURX / S&P CURX unavailable / 14.29% |
| 2018-Q40/3 |
LoseCURX / S&P CURX unavailable / -13.52% |
LoseCURX / S&P CURX unavailable / 9.05% |
LoseCURX / S&P CURX unavailable / 18.23% |
| 2018-Q30/3 |
LoseCURX / S&P CURX unavailable / 7.71% |
LoseCURX / S&P CURX unavailable / 10.21% |
LoseCURX / S&P CURX unavailable / 19.06% |
| 2018-Q20/3 |
LoseCURX / S&P CURX unavailable / 3.43% |
LoseCURX / S&P CURX unavailable / 9.03% |
LoseCURX / S&P CURX unavailable / 14.46% |
| 2018-Q10/3 |
LoseCURX / S&P CURX unavailable / -0.76% |
LoseCURX / S&P CURX unavailable / 7.68% |
LoseCURX / S&P CURX unavailable / 12.46% |
| 2017-Q40/3 |
LoseCURX / S&P CURX unavailable / 6.64% |
LoseCURX / S&P CURX unavailable / 7.03% |
LoseCURX / S&P CURX unavailable / 13.82% |
| 2017-Q30/3 |
LoseCURX / S&P CURX unavailable / 4.48% |
LoseCURX / S&P CURX unavailable / 5.68% |
LoseCURX / S&P CURX unavailable / 17.57% |
| 2017-Q20/3 |
LoseCURX / S&P CURX unavailable / 3.09% |
LoseCURX / S&P CURX unavailable / 4.83% |
LoseCURX / S&P CURX unavailable / 17.74% |
| 2017-Q10/3 |
LoseCURX / S&P CURX unavailable / 6.07% |
LoseCURX / S&P CURX unavailable / 3.67% |
LoseCURX / S&P CURX unavailable / 13.32% |
| 2016-Q40/3 |
LoseCURX / S&P CURX unavailable / 3.82% |
LoseCURX / S&P CURX unavailable / 2.09% |
LoseCURX / S&P CURX unavailable / 7.05% |
| 2016-Q30/3 |
LoseCURX / S&P CURX unavailable / 3.85% |
LoseCURX / S&P CURX unavailable / 0.20% |
LoseCURX / S&P CURX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CURX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -16.43% | 20.78% |
| Annualized return | -16.43% | 20.78% |
5Y · 2025-08-26 to 2026-08-27
| Metric | CURX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 16.42% | 83.14% |
| Annualized return | 3.09% | 12.86% |
10Y · 2025-08-26 to 2026-08-27
| Metric | CURX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 16.42% | 319.30% |
| Annualized return | 1.53% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |